Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival.

Franz Thiele,Ariane Klein,Jens Klotsche,Daniel Windschall,Frank Dressler,Jasmin Kuemmerle-Deschner,Kirsten Minden,Ivan Foeldvari,Dirk Foell,Sonja Mrusek,Prasad Thomas Oommen,Gerd Horneff

Rheumatology (Oxford, England)（2022）

引用 2|浏览25

暂无评分

摘要

Additionally given MTX improves the effectiveness of biologic treatment in polyarticular JIA without seriously compromising treatment safety. Especially TNFi benefit from combination, while no improvement in outcome has been observed by combining tocilizumab with MTX.

查看译文

关键词

Biological therapies,DMARDs,Juvenile idiopathic arthritis,Methotrexate,observational research

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要